Dashboard
Manage Tickers

NVO


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

eli-lilly-novo-nordisk-hims--hers-health-shares-move-lower-after-trump-calls-out-fat-loss-drugs
Eli Lilly, Novo Nordisk, Hims & Hers Healt...
10/16/2025 21:24:18

Shares of Eli Lilly and Novo Nordisk move lower in Thursday's after-hours session after President Trump indicated weight-lo...

Core News & Articles
President Trump Says I Think The Fat-Loss...
10/16/2025 20:33:25

https://www.youtube.com/watch?v=xagrobF4q1k 

whats-driving-the-market-sentiment-around-novo-nordisk-as
What's Driving the Market Sentiment Around...
10/16/2025 20:01:02

hims--hers-stocks-150-surge-is-all-fundamentalsno-novo-no-problem
Hims & Hers Stock's 150% Surge Is All Fund...
10/16/2025 14:41:29

Hims & Hers (HIMS) has seen surprising success, up 150% YTD, driven by their new menopause specialty and refocusing on heal...

update-novo-nordisk-says-us-fda-approves-addition-of-intestinal-obstruction-severe-constipation-from-recent-major-changes-on-wegovys-prescribing-info
UPDATE: Novo Nordisk Says U.S. FDA Approve...
10/15/2025 19:12:53

https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/215256s024lbl.pdf

novo-nordisk-says-us-fda-approves-wegovys-supplemental-new-drug-application-as-amended-for-labeling-with-minor-editorial-revisions
Novo Nordisk Says U.S. FDA Approves Wegovy...
10/15/2025 19:09:30

https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/215256s024lbl.pdf

omeros-stock-skyrockets-after-novo-nordisk-strikes-21b-rare-disease-drug-deal
Omeros Stock Skyrockets After Novo Nordisk...
10/15/2025 18:58:04

Omeros stock jumps 164% as Novo Nordisk acquires global rights to zaltenibart, with potential milestones reaching $2.1 billion ...

novo-nordisk-begins-round-of-layoffs-in-united-states-sources-say--reuters
'Novo Nordisk begins round of layoffs in U...
10/15/2025 13:51:12

https://www.reuters.com/world/novo-nordisk-begins-round-layoffs-united-states-sources-say-2025-10-15/

Core News & Articles
Novo Nordisk Acquires Global Rights To Zal...
10/15/2025 12:34:16

Zaltenibart has best-in-class potential across multiple rare blood and kidney disorders and will enhance Novo Nordisk's Rar...

bmo-capital-maintains-market-perform-on-novo-nordisk-raises-price-target-to-55
BMO Capital Maintains Market Perform on No...
10/14/2025 18:02:31

BMO Capital analyst Evan David Seigerman maintains Novo Nordisk (NYSE:NVO) with a Market Perform and raises the price target...

why-is-scholar-rock-stock-trading-lower-on-monday
Why Is Scholar Rock Stock Trading Lower On...
10/13/2025 17:52:35

Scholar Rock stock falls as FDA issues Form 483 to Catalent; company to meet FDA, while apitegromab shows lean mass preservatio...

Core News & Articles
Scholar Rock Says Novo Nordisk Informed, F...
10/13/2025 13:38:42

https://scholarrock.com/our-company/newsroom/update-on-third-party-manufacturing-site/

novo-nordisk-responds-to-earlier-report-of-halting-cell-therapy-for-diabetes-says-decided-to-discontinue-our-cell-therapy-rd-efforts-in-process-of-identifying-partners-with-right-capabilities--manufacturing-capacity-to-further-develop-innovations-we-will-not-share-additional-details-about-individual-sites-or-areas-affected-by-discontinuation-of-cell-therapy-rd-efforts
Novo Nordisk Responds To Earlier Report Of...
10/10/2025 20:17:43

- Reuters

bill-gates-and-paho-push-to-make-weight-loss-drugs-accessible-in-low-income-nations
Bill Gates And PAHO Push To Make Weight-Lo...
10/10/2025 17:58:32

Bill Gates and PAHO are working to make weight-loss drugs like Wegovy and Mounjaro more affordable for low-income countries.

novo-halts-work-on-cell-therapy-cure-for-diabetes-to-cut-costs--bloomberg
'Novo Halts Work on Cell Therapy Cure for ...
10/10/2025 15:45:50

https://www.bloomberg.com/news/articles/2025-10-10/novo-halts-work-on-cell-therapy-cure-for-diabetes-to-cut-costs?taid=68e928f9...

novo-nordisk-to-acquire-liver-disease-focused-akero-therapeutics-for-around-5-billion
Novo Nordisk To Acquire Liver Disease Focu...
10/09/2025 13:10:21

Novo Nordisk to buy Akero Therapeutics for up to $5.2 billion, adding EFX, a late-stage MASH treatment candidate, to its metabo...

Core News & Articles
Novo Nordisk To Acquire Akero Therapeutics...
10/09/2025 10:03:27

wegovy-ozempic-maker-novo-nordisk-cuts-staff-at-key-us-production-sites
Wegovy, Ozempic Maker Novo Nordisk Cuts St...
10/07/2025 17:57:21

Novo Nordisk has cut dozens of jobs at its Clayton, North Carolina site, part of a global restructuring as it faces slowing wei...

novo-nordisk-cuts-dozens-at-us-wegovy-manufacturing-plant-amid-global-9000-job-restructuring-plan
Novo Nordisk Cuts Dozens At US Wegovy Manu...
10/07/2025 06:56:40

-Reuters 

skye-biosciences-investigational-drug-disappoints-as-monotherapy-for-weight-loss
Skye Bioscience's Investigational Drug Dis...
10/06/2025 14:39:32

Skye Bioscience'a trial showed nimacimab alone missed goals, while a combo with Novo Nordisk's drug delivered stronger ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION